Natural Health Trends Corp

Natural Health Trends Corp(NHTC)股票分析

$1.600

-0.103 (-6.43%)收盤時

Loading chart…
High
1.675
Open
1.650
VWAP
1.62
Vol
39.93K
Mkt Cap
81.08M
Low
1.600
Amount
64.88K
EV/EBITDA, TTM
0.00

Natural Health Trends Corp. is a direct-selling and e-commerce company. The Company offers a line of NHT Global branded products in categories which include wellness, herbal, beauty, lifestyle and at-home tests. Its wellness products are formulated and designed to meet specific wellness goals, which include nutrition for joint health, antioxidant support, digestive health, heart health, vision health, immune support and cellular health. Its beauty product line includes age-defying and hydrating cleansers, creams, lotions, serums and toners to moisturize, protect and improve the appearance of skin. Its lifestyle products support active, physical and healthy lifestyles, including weight management, and energy-enhancing supplements. Its wellness products include Triotein, Cluster X2, ReStor Silver, and Glucosamine 2200. Its herbal products include LivaPro, Cordyceps Mycelia CS-4, and RespFactor. Its beauty products include Skindulgence Essence Gel, Floraeda Toner and Primer.

AI analysis of Natural Health Trends Corp (NHTC)

sell

NHTC is not a good buy right now due to its current price of 1.60, a very low RSI of 25.17 indicating oversold conditions, and a significant year-to-date change of -48.05%. The company is facing declining revenues and increasing losses, with a net income of -451,000 in Q2 2026. The main risk is the ongoing sales decline, with a 23% drop year-over-year in Q2 2026, which raises concerns about the sustainability of the business.

估值指標

The current forward P/E ratio for Natural Health Trends Corp (NHTC) is 13.44, compared to its 5-year average forward P/E of 2.06.

Forward P/E

Strongly Overvalued
5Y Average P/E
2.06
Current P/E
13.44
高估
7.55
低估
-3.42

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
高估
0.00
低估
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
高估
0.00
低估
0.00

Alphio AI Price Scenarios for NHTC

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%NHTC

$5.32

情境價格

B

Base

Base · 50%NHTC

$4.76

情境價格

B

Bear

Bear · 25%NHTC

$4.39

情境價格

事件時間軸

2026-02-17 (ET)

16:50:00

Natural Health Repurchases Shares from George K. Broady Family for $5.9M

2026-02-04 (ET)

09:10:00

Natural Health Trends Corp Q4 Revenue at $9.7M

2025-11-05 (ET)

09:03:54

Natural Health Trends announces Q3 EPS of 4 cents compared to 0 cents in the previous year.

2025-07-30 (ET)

09:02:00

Natural Health Trends reports Q2 EPS 0c vs 2c last year

2025-04-30 (ET)

09:07:07

Natural Health Trends reports Q1 EPS 1c vs 2c last year

資訊

NHTC FAQ — answered by Alphio AI

Natural Health Trends Corp. is a direct-selling and e-commerce company. The Company offers a line of NHT Global branded products in categories which include wellness, herbal, beauty, lifestyle and at-home tests. Its wellness products are formulated and designed to meet specific wellness goals, which include nutrition for joint health, antioxidant support, digestive health, heart health, vision health, immune support and cellular health. Its beauty product line includes age-defying and hydrating cleansers, creams, lotions, serums and toners to moisturize, protect and improve the appearance of skin. Its lifestyle products support active, physical and healthy lifestyles, including weight management, and energy-enhancing supplements. Its wellness products include Triotein, Cluster X2, ReStor Silver, and Glucosamine 2200. Its herbal products include LivaPro, Cordyceps Mycelia CS-4, and RespFactor. Its beauty products include Skindulgence Essence Gel, Floraeda Toner and Primer. It operates in the Consumer Cyclicals sector (WHOLESALE-MISCELLANEOUS NONDURABLE GOODS industry).

NHTC is not a good buy right now due to its current price of 1.60, a very low RSI of 25.17 indicating oversold conditions, and a significant year-to-date change of -48.05%. The company is facing declining revenues and increasing losses, with a net income of -451,000 in Q2 2026. The main risk is the ongoing sales decline, with a 23% drop year-over-year in Q2 2026, which raises concerns about the sustainability of the business.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始